Skip to main content
SpringerLink
Log in

Pharmacokinetics and molecular docking of novel antineoplastic sesquiterpene lactone from Tarchonanthus camphoratus L: an in silico approaches

  • Original Research
  • Published:
Structural Chemistry Aims and scope Submit manuscript

Abstract

Natural products are important in drug discovery because they provide structural clues for the creation of novel therapeutic treatments for a variety of ailments. The present study aims to focus on the in silico assessment of the therapeutic potential of phytochemical compounds isolated from Tarchonanthus camphoratus L. The physicochemical and pharmacokinetic parameters of the three identified compounds were predicted using various integrated web-based tools. Following that, the PharmMapper web server was used to undertake structural-based virtual screening for the probable targets. Based on the findings, molecular docking was then used to investigate the binding interactions between the most promising lead and the targets indicated by the PharmMapper server. The obtained results revealed that the hydrogen bonds and total polar surface area for all compounds were within the limit range stated for Lipinski’s rule of five and subsequently easily transported. However, only trifloculoside was found to be soluble (Log P = 2.3), permeable with no violation. Trifloculoside was suggested as potential antineoplastic agent based on its activity, safety, and binding energy to the target (− 6.8 kcal/mol). The obtained molecular dynamic simulation results were further supported the stability and flexibility of the complex. These findings suggest trifloculoside could be used as a starting point for future drug development initiatives in chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Availability of data and materials

All dataset supporting this article is available within the article.

References

  1. TahirUlQamar MT, Arooma M, Muneer I, Xing F, Ashfaq UA, Khan FA, Anwar F, Geesi MH, Khalid RR, Abdul RS (2019) Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus. Sci Re 9:1–16

    CAS  Google Scholar 

  2. Osman W, Ibrahim M, Adam M, Mothana R, Mohammed M, Abdoon I et al (2019) Isolation and characterization of four terpenoidal compounds with potential antimicrobial activity from Tarchonanthus camphoratus L. (Asteraceae). J Pharm Bioall Sci 11:373–6

  3. Mwangi JW, Achola KJ et al (1994) Volatile constituents of the essential oil of Tarchonanthus camphoratus L. J Essen Oil Res 6:183–185

    Article  CAS  Google Scholar 

  4. Bishay DW, Attia AA (2002) Fayed, M.A. Flavones and a quaternary alkaloid from Tarchonanthus camphoratus L. Bull Pharm Sci Assiut Univ 25(1): 1–6

  5. Nasr FA, Noman OM, Alqahtani AS, Qamar W, Ahamad SR, Al-Mishari AA, Alyhya N, Farooq M (2020) Phytochemical constituents and anticancer activities of Tarchonanthus camphoratus essential oils grown in Saudi Arabia. Saudi Pharm J 28(11):1474–1480. https://doi.org/10.1016/j.jsps.2020.09.013.

  6. Ali NA, Al-Fatimi MA, Crouch RA, Denkert A, Setzer WN, Wessjohann L (2002) Antimicrobial, antioxidant, and cytotoxic activities of the essential oil of Tarchonanthus camphoratus. Nat Prod Commun 8(5):683–686

    Google Scholar 

  7. Knight DW (1995) Feverfew: chemistry and biological activity. Nat Prod Rep 12:271–276

    Article  CAS  PubMed  Google Scholar 

  8. Amabeoku GJ, Green I, Eagles P, Benjeddou M (2000) Effects of Tarchonanthus camphoratus and Eriocephalus africanus on nociception in mice and pyrexia in rats. Phytomedicine 7:517–522

    Article  CAS  PubMed  Google Scholar 

  9. Xie XQ, Wang L, Wang J, Xie Z, Yang P, Ouyang Q (2016) Chapter 19 - In silico chemogenomics knowledgebase and computational system neuropharmacology approach for cannabinoid drug research, neuropathology of drug addictions and substance misuse. Academic Press 183–195

  10. Makhouri FR, Ghasemi JB (2018) In silico studies in drug research against neurodegenerative diseases. Curr Neuro pharmacol 16(6):664–725. https://doi.org/10.2174/1570159×15666170823095628.PMID:28831921;PMCID:PMC6080098

    Article  CAS  Google Scholar 

  11. Osman W, Ismail EM, Shantier SW, Mohammed MS, Mothana RA, Muddathir A, Khalid HS (2021) In silico assessment of potential leads identified from Bauhinia rufescens Lam. as α-glucosidase and α-amylase inhibitors. J Recep Sig Trans 41(2):159–169

  12. Osman W, Mohammed MS, Khalid HS, Muddathir A, Shantier SW, Osman B, Abdoon I (2020) HPTLC fingerprint profile and identification of antidiabetic and antioxidant Leads from from Bauhinia rufescence L. Advan in Pharmacol Pharma Sci Article ID 3201463

  13. Ekor M (2014) The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 10(4):177. https://doi.org/10.3389/fphar.2013.00177.PMID:24454289;PMCID:PMC3887317

    Article  Google Scholar 

  14. Molinspiration chemoinformatics (1986) Novaulica, SK-900 26 Slovensky Grob, Slovak Republic

  15. Filimonov DA, Lagunin AA, Gloriozova TA, Rudik AV, Druzhilovskii DS, Pogodin PV, Poroikov VV (2014) Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem Heterocycl Compd 50(3):444–457

    Article  CAS  Google Scholar 

  16. Schrodinger Release (2020) 3: Maestro, Schrodinger, LLC, New York, 2020

  17. Daina A, Michielin O, Zoete V (2017) Swiss ADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717

    Article  PubMed  PubMed Central  Google Scholar 

  18. O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminf 3:33

    Article  Google Scholar 

  19. Xia W, Yihang S, Shiwei W, Shiliang L, Weilin Z, Xiaofeng L, Luhua L, Jianfeng P, Honglin L (2017) PharmMapper: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res 45:W356–W360

    Article  Google Scholar 

  20. Guex N, Peitsch MC (1997) SWISS-MODEL and the swiss-Pdb viewer: an environment for comparative protein modeling. Electrophoresis 18:2714–2723

    Article  CAS  PubMed  Google Scholar 

  21. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785–2791

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK et al (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639–1662

    Article  CAS  Google Scholar 

  23. WebGRO for macromolecular simulations. https://simlab.uams.edu/.

  24. Schüttelkopf AW, van Aalten DMF (2004) PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr 60(8):1355–1363. https://doi.org/10.1107/S0907444904011679

    Article  CAS  Google Scholar 

  25. Paramashivam SK, Elayaperumal K, Natarajan BB, Ramamoorthy MD, Balasubramanian S, Dhiraviam KN (2015) In silico pharmacokinetic and molecular docking studies of small molecules derived from Indigofera aspalathoides Vahl targeting receptor tyrosine kinases. Bioinformation 11:73–84

    Article  PubMed  PubMed Central  Google Scholar 

  26. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 46:3–26

    Article  CAS  Google Scholar 

  27. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615–2623

    Article  CAS  PubMed  Google Scholar 

  28. Srimai V, Ramesh M, Parameshwar KS, Parthasarathy T (2013) Computer-aided design of selective cytochrome P450 inhibitors and docking studies of alkylresorcinol derivatives. Med Chem Res 22:5314–5323

    Article  CAS  Google Scholar 

  29. Bergström CA, Charman WN, Porter CJ (2016) Computational prediction of formulation strategies for beyond-rule-of-5 compounds. Adv Drug Deliv Rev 101:6–21

    Article  PubMed  Google Scholar 

  30. Kurt M, Babu PC, Sundaraganesan N, Cinar M, Karabacak M (2011) Molecular structure, vibrational, UV and NBO analysis of 4-chloro-7-nitrobenzofurazan by DFT calculations. Spectrochim Acta, Part A 79:1162–1170

    Article  CAS  Google Scholar 

  31. Gunasekaran S, Balaji RA, Kumeresan S, Anand G, Srinivasan S (2008) Experimental and theoretical investigations of spectroscopic properties of N-acetyl-5-methoxytryptamine. Can J Anal Sci Spectrosc 53:149–160

    CAS  Google Scholar 

  32. Murray JS, Politzer P (2011) The electrostatic potential: an overview. Comput Mol Sci 1:153–163

    Article  CAS  Google Scholar 

  33. Murray JS, Politzer P (2017) Molecular electrostatic potentials and noncovalent interactions. Comput Mol Sci 7:1–10

    Article  Google Scholar 

  34. Townsend D, Tew K (2003) The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369–7375

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Ruscoe JE, Rosario LA, Wang T, Gaté L, Arifoglu P, Wolf CR, Henderson CJ, Ronai Z, Tew KD (2008) Pharmacologic or genetic manipulation of glutathione S-transferase P1–1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 298(1):339–345

    Google Scholar 

  36. Sau A, Tregno FP, Valentino F, Federici G, Caccuri AM (2010) Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys 500:116–122

    Article  CAS  PubMed  Google Scholar 

  37. Federici L, Lo Sterzo C, Pezzola S, Di Matteo A, Scaloni F, Federici G et al (2009) Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione S-transferases. Cancer Res 69:8025–8034

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Khartoum, P.O. Box 1996, Khartoum, Sudan

    Shaza W. Shantier & Esraa M. O. Ismail

  2. Department of Pharmacognosy, Faculty of Pharmacy, University of Khartoum, P.O. Box 1996, Khartoum, Sudan

    Mona S. Mohamed & Wadah Osman

Authors
  1. Shaza W. Shantier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Esraa M. O. Ismail
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mona S. Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wadah Osman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S. S. conducted the in silico analysis and docking and wrote the abstract, methodology, results, and conclusion sections; E. O. wrote the discussion of the pharmacological work and contributed in the discussion of MD simulation and docking; M. M. wrote the introduction; W. O. conducted the isolation of compounds and revised the paper draft. All authors approved the final draft.

Corresponding author

Correspondence to Shaza W. Shantier.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (XLSX 9 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shantier, S.W., Ismail, E.M.O., Mohamed, M.S. et al. Pharmacokinetics and molecular docking of novel antineoplastic sesquiterpene lactone from Tarchonanthus camphoratus L: an in silico approaches. Struct Chem 34, 703–712 (2023). https://doi.org/10.1007/s11224-022-02016-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11224-022-02016-9

Keywords

Search

Navigation